🇺🇸 FDA
Patent

US 12247021

Substituted tetrahydrofurans as modulators of sodium channels

granted A61PA61P29/00

Quick answer

US patent 12247021 (Substituted tetrahydrofurans as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P29/00